Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
November 3, 2001
Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma
M Volkmann, J H Schiff, Y Hajjar, et al.
The Journal of Experimental Medicine
|
November 1, 1995
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
P R Galle, W J Hofmann, H Walczak, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1993
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status
M Volkmann, M Müller, W J Hofmann, et al.
Transplantation Proceedings
|
February 1, 1995
Lack of preferential Th1/Th2 cytokine gene expression patterns in both alpha/beta T-cell-tolerant and -rejecting rat cardiac allografts
W J Hofmann, C Dufter, P Terness, et al.
Microvascular Research
|
August 25, 1999
Thermodiffusion for continuous quantification of hepatic microcirculation--validation and potential in liver transplantation
E Klar, T Kraus, J Bleyl, et al.
Zeitschrift Fur Gastroenterologie
|
January 1, 1997
[Coincidence of primary sclerosing cholangitis and sarcoidosis--case report and review of the literature]
K Keller, W J Hofmann, K Kayser, et al.
Pathology, Research and Practice
|
November 10, 2001
Hepatic failure with neonatal tissue siderosis of hemochromatotic type in an infant presenting with meconium ileus. Case report and differential diagnosis of the perinatal iron storage disorders
C Sergi, U Himbert, F Weinhardt, et al.
The Journal of Clinical Investigation
|
February 1, 1997
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
M Müller, S Strand, H Hug, et al.
Nature Medicine
|
December 1, 1996
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
S Strand, W J Hofmann, H Hug, et al.
Cancer Research
|
May 15, 1997
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma
X Li, Z Nong, C Ekström, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Journal of Molecular Medicine (Berlin, Germany)
|
November 3, 2001
Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma
M Volkmann, J H Schiff, Y Hajjar, et al.
The Journal of Experimental Medicine
|
November 1, 1995
Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
P R Galle, W J Hofmann, H Walczak, et al.
Hepatology (Baltimore, Md.)
|
September 1, 1993
The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the alpha-fetoprotein status
M Volkmann, M Müller, W J Hofmann, et al.
Transplantation Proceedings
|
February 1, 1995
Lack of preferential Th1/Th2 cytokine gene expression patterns in both alpha/beta T-cell-tolerant and -rejecting rat cardiac allografts
W J Hofmann, C Dufter, P Terness, et al.
Microvascular Research
|
August 25, 1999
Thermodiffusion for continuous quantification of hepatic microcirculation--validation and potential in liver transplantation
E Klar, T Kraus, J Bleyl, et al.
Zeitschrift Fur Gastroenterologie
|
January 1, 1997
[Coincidence of primary sclerosing cholangitis and sarcoidosis--case report and review of the literature]
K Keller, W J Hofmann, K Kayser, et al.
Pathology, Research and Practice
|
November 10, 2001
Hepatic failure with neonatal tissue siderosis of hemochromatotic type in an infant presenting with meconium ileus. Case report and differential diagnosis of the perinatal iron storage disorders
C Sergi, U Himbert, F Weinhardt, et al.
The Journal of Clinical Investigation
|
February 1, 1997
Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53
M Müller, S Strand, H Hug, et al.
Nature Medicine
|
December 1, 1996
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?
S Strand, W J Hofmann, H Hug, et al.
Cancer Research
|
May 15, 1997
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma
X Li, Z Nong, C Ekström, et al.
Page
of 9